中亦科技：10月23日召开董事会会议

Group 1 - The core point of the article is that Zhongyi Technology (SZ 301208) held its eighth meeting of the fifth board of directors on October 23, 2025, to review the third quarter report for 2025 [1] - For the first half of 2025, Zhongyi Technology's revenue composition is as follows: banks account for 48.11%, other financial institutions for 26.57%, other industries for 17.76%, manufacturing for 3.94%, and government for 3.61% [1] - As of the report, Zhongyi Technology has a market capitalization of 4.8 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year [1] - There is a discussion about the hot secondary market in biomedicine, while the primary market is facing challenges in fundraising [1]